All Releases All Releases MAR Regulatory Releases Selected Company Releases News Category AllAll ReleasesMAR Regulatory ReleasesSelected Company Releases Year All202620252024202320222021202020192018 Aug 10, 2026 Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company Aug 6, 2026 Oculis Reports Q2 2026 Financial Results and Provides Company Update Aug 3, 2026 Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses Jul 8, 2026 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities Jul 2, 2026 Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference Jul 2, 2026 Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference Jun 15, 2026 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities Jun 11, 2026 Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026 Jun 10, 2026 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities Jun 9, 2026 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
